Infarinato Robert M. 4
4 · Phio Pharmaceuticals Corp. · Filed Aug 15, 2024
Insider Transaction Report
Form 4
Infarinato Robert M.
VP, Chief Financial Officer
Transactions
- Award
Common stock, $0.0001 par value
2024-08-13+8,000→ 8,000 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date.
- [F2]Includes shares of common stock underlying unvested restricted stock units.